Literature DB >> 9530540

Risk factors for the spread of antibiotic-resistant bacteria.

G G Rao1.   

Abstract

The emergence of antibiotic resistance is primarily due to excessive and often unnecessary use of antibiotics in humans and animals. Risk factors for the spread of resistant bacteria in hospitals and the community can be summarised as over-crowding, lapses in hygiene or poor infection control practices. Increasing antibiotic resistance in bacteria has been exacerbated by the slow pace in developing newer antibiotics. Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE) and multiresistant Gram-negative bacteria are spread primarily by direct or indirect person-to-person contact. Independent risk factors for MRSA include the use of broad spectrum antibiotics, the presence of decubitus ulcers and prosthetic devices while those for VRE include prolonged hospitalisation and treatment with glycopeptides or broad spectrum antibiotics. For the spread of resistant Gram-negative bacteria risk factors include urinary catheterisation, excessive use of antibiotics and contamination of humidifiers and nebulisers. The spread of penicillin-resistant pneumococci (PRP) and drug-resistant and multidrug-resistant tuberculosis (MDRTb) is due to airborne transmission. Risk factors for the spread of PRP include overcrowding, tracheostomies and excessive use of penicillins for viral respiratory infections; for MDRTb they include poor compliance, convergence of immunosuppressed patients, delayed diagnosis or treatment, and poor or inadequate ventilation and isolation facilities. Recent developments in the genomic mapping of many bacteria and advances in combinatorial chemistry promise to usher in a new era of antibiotic development. While this may result in our regaining some of the ground lost to resistant bacteria, there will still be a continuing need to minimise the spread of antibiotic resistance through the rational use of antibiotic agents and stringent infection control practice.

Entities:  

Mesh:

Year:  1998        PMID: 9530540     DOI: 10.2165/00003495-199855030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  22 in total

1.  Hospital outbreak of multiresistant Streptococcus pneumoniae.

Authors:  T D Cartmill; H Panigrahi
Journal:  J Hosp Infect       Date:  1992-02       Impact factor: 3.926

2.  Nosocomial transmission of multidrug-resistant tuberculosis to health-care workers and HIV-infected patients in an urban hospital--Florida.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-10-12       Impact factor: 17.586

3.  Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.

Authors:  B E Murray; K V Singh; S M Markowitz; H A Lopardo; J E Patterson; M J Zervos; E Rubeglio; G M Eliopoulos; L B Rice; F W Goldstein
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

Review 4.  Probiotics in human medicine.

Authors:  R Fuller
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

5.  Vancomycin-resistant gram-positive cocci: risk factors for faecal carriage.

Authors:  G G Rao; F Ojo; D Kolokithas
Journal:  J Hosp Infect       Date:  1997-01       Impact factor: 3.926

Review 6.  Treatment of multidrug-resistant tuberculosis.

Authors:  M D Iseman
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

7.  Resistance to antibiotics at medical centres in different parts of the world.

Authors:  T F O'Brien
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

8.  Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients.

Authors:  P N Wenger; J Otten; A Breeden; D Orfas; C M Beck-Sague; W R Jarvis
Journal:  Lancet       Date:  1995-01-28       Impact factor: 79.321

9.  Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.

Authors:  C Beck-Sagué; S W Dooley; M D Hutton; J Otten; A Breeden; J T Crawford; A E Pitchenik; C Woodley; G Cauthen; W R Jarvis
Journal:  JAMA       Date:  1992-09-09       Impact factor: 56.272

10.  Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man.

Authors:  J Bates; J Z Jordens; D T Griffiths
Journal:  J Antimicrob Chemother       Date:  1994-10       Impact factor: 5.790

View more
  38 in total

1.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  [Epidemiology of multidrug-resistant organisms in travellers: Results of a 2-year screening in a German level 1 trauma center].

Authors:  J Seifert; M Frank; T Köln; K Beniers; A Kramer; A Ekkernkamp; D Gümbel
Journal:  Unfallchirurg       Date:  2016-03       Impact factor: 1.000

Review 3.  Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance.

Authors:  Peter Gilbert; Andrew J McBain
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

4.  Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infections.

Authors:  A Mujal; J Sola; M Hernandez; M-A Villarino; M-L Machado; M Baylina; J Tajan; J Oristrell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-06       Impact factor: 3.267

Review 5.  Antimicrobial Stewardship: A Call to Action for Surgeons.

Authors:  Massimo Sartelli; Therese M Duane; Fausto Catena; Jeffrey M Tessier; Federico Coccolini; Lillian S Kao; Belinda De Simone; Francesco M Labricciosa; Addison K May; Luca Ansaloni; John E Mazuski
Journal:  Surg Infect (Larchmt)       Date:  2016-11-09       Impact factor: 2.150

Review 6.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

7.  Beneficial effects of implementing guidelines on microbiology and costs of infected diabetic foot ulcers.

Authors:  A Sotto; J-L Richard; C Combescure; N Jourdan; S Schuldiner; N Bouziges; J-P Lavigne
Journal:  Diabetologia       Date:  2010-06-23       Impact factor: 10.122

8.  Methicillin-resistant Staphylococcus non-aureus infection in an irradiated rhesus macaque (Macaca mulatta).

Authors:  Krishnan Kolappaswamy; Steven T Shipley; Ivan I Tatarov; Louis J DeTolla
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

Review 9.  Hypersensitivity reactions to beta-lactam antibiotics.

Authors:  Roland Solensky
Journal:  Clin Rev Allergy Immunol       Date:  2003-06       Impact factor: 8.667

10.  Lower gastrointestinal tract tuberculosis: an important but neglected disease.

Authors:  Pei-Ying Lin; Jann-Yuan Wang; Po-Ren Hsueh; Li-Na Lee; Cheng-Hsiang Hsiao; Chong-Jen Yu; Pan-Chyr Yang
Journal:  Int J Colorectal Dis       Date:  2009-05-07       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.